Cardiotrophin-1 mediates the effect of blood pressure on left ventricular mass in severe obesity, suggesting it may be a biomarker or therapeutic target in obesity-associated hypertrophy.
Does Cardiotrophin-1 mediate the effect of systolic blood pressure on left ventricular hypertrophy in severe obesity?
Cardiotrophin-1 may serve as a biomarker or therapeutic target for obesity-associated left ventricular hypertrophy.
Absolute Event Rate: 0% vs 0%
CT-1 mediates the effect of BP on LV mass in severe obesity, suggesting that CT-1 may be a biomarker or therapeutic target in obesity-associated LVH.
Hsuan et al. (Thu,) reported a other. Cardiotrophin-1 mediates the effect of blood pressure on left ventricular mass in severe obesity, suggesting it may be a biomarker or therapeutic target in obesity-associated hypertrophy.